Home » Stocks » LNTH

Lantheus Holdings, Inc. (LNTH)

Stock Price: $20.77 USD 0.96 (4.85%)
Updated May 13, 2021 4:00 PM EDT - Market closed
After-hours: $20.49 -0.29 (-1.37%) May 13, 4:11 PM
Market Cap 1.36B
Revenue (ttm) 341.22M
Net Income (ttm) -7.80M
Shares Out 67.09M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE 52.91
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $20.77
Previous Close $19.81
Change ($) 0.96
Change (%) 4.85%
Day's Open 19.88
Day's Range 19.60 - 20.96
Day's Volume 1,110,362
52-Week Range 10.52 - 24.26

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 600.00% and 5.54%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share fell 86.11% over the past year to $0.05, which beat the estimate...

1 week ago - Benzinga

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

1 week ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--EXINI Diagnostics AB, a subsidiary of Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imagin...

1 week ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

1 week ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Tuesday, May 4, 2021, t...

3 weeks ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

1 month ago - Business Wire

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Facebook & Micron

Other stocks mentioned: FB, MU, BHE, MRVL
1 month ago - CNBC

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

1 month ago - Business Wire

Lantheus Holdings Inc (NASDAQ: LNTH) has acquired the exclusive worldwide rights to develop, manufacture and commercialize NTI-1309, a PET oncology imaging agent from Noria Therapeutics Inc. NTI-1309 ta...

1 month ago - Benzinga

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

1 month ago - Business Wire

Lantheus Holdings (LNTH) has moved higher as of late, but there could definitely be trouble on the horizon for this company

1 month ago - Zacks Investment Research

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

1 month ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

2 months ago - Business Wire

Shares of Lantheus Holdings (NASDAQ:LNTH) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 79.41% year over year to $0.07, which beat th...

2 months ago - Benzinga

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

2 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics a...

3 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 4:30 p.m. ET on Thursday, February 25, ...

3 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global le...

3 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader ...

4 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (the Company), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global lead...

5 months ago - Business Wire

Is Lantheus Holdings (LNTH) a great pick from the value investor's perspective right now? Read on to know more.

5 months ago - Zacks Investment Research

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., a global leader in t...

5 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (the Company), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global lead...

5 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global le...

5 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global le...

5 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXINI Diagnost...

6 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnosti...

6 months ago - Business Wire

Lantheus Holdings, Inc.'s (LNTH) CEO Mary Anne Heino on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 200.00% and -6.60%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global le...

6 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnosti...

6 months ago - Business Wire

Lantheus Holdings (LNTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture...

6 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 5, 2...

6 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXINI Diagnost...

7 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global le...

7 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc.

8 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc.

9 months ago - Business Wire

Lantheus Holdings, Inc.'s (LNTH) CEO Mary Anne Heino on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc.

9 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc.

9 months ago - Business Wire

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global le...

10 months ago - Business Wire

NORTH BILLERICA, Mass. & NEW YORK--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the developme...

10 months ago - Business Wire

Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected at $14.03 after the company reported Q1 results.

1 year ago - Benzinga

Lantheus Holding, Inc. (LNTH) CEO Mary Anne Heino on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Lantheus Holding Inc. (LNTH) CEO Mary Anne Heino on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 12.00% and 2.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Lantheus Holdings (LNTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

About LNTH

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable T... [Read more...]

Industry
Diagnostics & Research
IPO Date
Jun 25, 2015
CEO
Mary Heino
Employees
595
Stock Exchange
NASDAQ
Ticker Symbol
LNTH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for LNTH stock is "Buy." The 12-month stock price forecast is 25.75, which is an increase of 23.98% from the latest price.

Price Target
$25.75
(23.98% upside)
Analyst Consensus: Buy